Dose Range Finding, Efficacy, and Safety Study of Nebulized CSL787 in Adults With Non-cystic Fibrosis Bronchiectasis (NCFB)
Clinical trial NCT07048262 · RECRUITING
Trial details
- NCT number
- NCT07048262
- Sponsor
- CSL Behring
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-03
- Primary completion
- 2028-02-28
- Enrollment
- 450
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.